ARTBIO is a Biotech company based in Cambridge, Massachusetts. It has raised $245M in total funding. Latest round: Series B.
ARTBIO is a Biotech company based in Cambridge, Massachusetts. ARTBIO has raised $245M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2024. The round record for ARTBIO runs through 2024; nothing later has been disclosed. Investors on record include F-Prime Capital, Omega Funds, Third Rock Ventures, Sofinnova Investments, B Capital, Qatar Investment Authority and 1 others. 7 distinct backers are named across the disclosed rounds.
We update the ARTBIO record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Cambridge and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026